对于持久疼痛的阿片类药物治疗患者进行药剂师主导的拟议实践审查的可接受性:旨在为干预开发提供信息的定性研究
Nicola Cornwall1, Charlotte Woodcock1, Julie Ashworth1,2
1School of Medicine, Keele University, Keele, UK.
British journal of pain
|May 16, 2024
概括
药剂师主导的疼痛评估 (PROMPPT) 是患者和药剂师可以接受的,用于管理长期使用阿片类药物. 早期优化改善了干预,为可行性研究铺平了道路.
科学领域:
- 药理学和药房实践中的药理学和药房实践
- 疼痛管理 疼痛管理
- 医疗保健干预发展 医疗保健干预发展
背景情况:
- 建议对长期服用阿片类药物治疗持续性非癌症疼痛 (PCNP) 的患者进行定期审查,但并非始终执行.
- 不适当的阿片类药物使用对PCNP构成了重大的公共卫生挑战.
- 由初级保健团队的临床药剂师领导的PROMPPT (长期服用阿片类药物治疗持续性疼痛的患者的积极临床审查) 计划旨在解决这一差距.
研究的目的:
- 探索拟议的药剂师主导疼痛评估 (PROMPPT) 干预措施的可接受性.
- 为初级保健提供PROMPPT干预措施的早期开发和优化提供信息.
- 为了减少患有持续疼痛的患者不适当的阿片类药物使用.
主要方法:
- 与患者 (n=46) 和药剂师 (n=13) 进行的定性访谈和在线讨论论坛探讨了潜在的可接受性.
- 一个原型PROMPPT审查被代测试并通过实践测试 (IPT) 在3个初级保健实践中进行了改进.
- 可接受性的理论框架 (TFA) 指导患者和药剂师反的演和诱导主题分析.
主要成果:
- 通过改进沟通材料,解决了患者对药剂师主导审查的初始不确定性.
- 在实施后,患者认为药剂师具有知识和资格进行疼痛评估.
- 药剂师最初发现审查具有挑战性,但报告说随着经验的增加,交付的便利性增加;建议优化培训.
结论:
- 在干预开发的多个阶段探索可接受性促进了PROMPPT原型的关键优化.
- 解决患者和提供者的看法是成功采用新医疗干预措施的关键.
- 优化的PROMPPT干预已准备好在非随机可行性研究中进行进一步评估.
相关概念视频
Analgesia and Pain Management
584
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
584
Opioid Analgesics: Synthetic and Semisynthetic Opioids
283
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
283
Opioid Analgesics: Morphine and Other Natural Cogeners
239
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
239
Opioid Receptors: Overview
749
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
749
Chronic Pancreatitis II: Collaborative Care
85
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
85
Pharmacovigilance
826
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
826


